Information Provided By:
Fly News Breaks for October 7, 2019
ALGN
Oct 7, 2019 | 07:48 EDT
Barclays analyst Steve Valiquette views his clear aligner survey last week to gauge U.S. trends for Q3 as positive for Align Technology. Based on the survey, the analyst believes the U.S. volume outlook looks solid, and his Align Technology revenue growth assumptions of 21% in 2019 and 23% in 2020 are unchanged. Further, respondents indicated there was no notable Invisalign discounting program in Q3 beyond the normal volume-tier discounts, Valiquette tells investors in a research note. The analyst lowered his price target for Align Technology to $272 from $300 and keeps an Overweight rating on the shares.
News For ALGN From the Last 2 Days
There are no results for your query ALGN